Published in Hum Mol Genet on April 01, 1999
Candidate gene studies of ADHD: a meta-analytic review. Hum Genet (2009) 3.56
Assessing the molecular genetics of attention networks. BMC Neurosci (2002) 2.02
MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction. Biol Psychiatry (2013) 1.79
Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques. Proc Natl Acad Sci U S A (2004) 1.71
Genetic approaches to addiction: genes and alcohol. Addiction (2008) 1.70
Serotonin, genetic variability, behaviour, and psychiatric disorders--a review. Ups J Med Sci (2010) 1.67
Orofacial pain prospective evaluation and risk assessment study--the OPPERA study. J Pain (2011) 1.62
Interaction of prenatal exposure to cigarettes and MAOA genotype in pathways to youth antisocial behavior. Mol Psychiatry (2009) 1.50
Early trauma and increased risk for physical aggression during adulthood: the moderating role of MAOA genotype. PLoS One (2007) 1.46
AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance. PLoS Genet (2005) 1.45
Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet (1999) 1.43
Monoamine oxidase a promoter variable number of tandem repeats (MAOA-uVNTR) in alcoholics according to Lesch typology. Int J Environ Res Public Health (2015) 1.39
MAOA genotype, maltreatment, and aggressive behavior: the changing impact of genotype at varying levels of trauma. Biol Psychiatry (2008) 1.32
Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J Clin Invest (2002) 1.31
MAOA genotype, childhood maltreatment, and their interaction in the etiology of adult antisocial behaviors. Biol Psychiatry (2013) 1.22
Genetics of human aggressive behaviour. Hum Genet (2009) 1.20
A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. Neuropsychopharmacology (2007) 1.17
Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)-a suitable endophenotype of schizophrenia. Front Hum Neurosci (2013) 1.10
Child maltreatment moderates the association of MAOA with symptoms of depression and antisocial personality disorder. J Fam Psychol (2010) 1.08
Genetics of anxiety and trauma-related disorders. Neuroscience (2009) 1.07
Association of dopamine transporter and monoamine oxidase molecular polymorphisms with sudden infant death syndrome and stillbirth: new insights into the serotonin hypothesis. Neurogenetics (2008) 1.05
Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am J Med Genet B Neuropsychiatr Genet (2008) 1.05
Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet (2008) 1.03
Brief report: aggression and stereotypic behavior in males with fragile X syndrome--moderating secondary genes in a "single gene" disorder. J Autism Dev Disord (2007) 1.03
Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biol Mood Anxiety Disord (2013) 1.01
Child abuse and neglect, MAOA, and mental health outcomes: a prospective examination. Biol Psychiatry (2011) 1.01
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neurosci Biobehav Rev (2011) 1.00
Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. Psychosom Med (2007) 1.00
Harsh discipline, childhood sexual assault, and MAOA genotype: an investigation of main and interactive effects on diverse clinical externalizing outcomes. Behav Genet (2010) 1.00
HPA axis function in male caregivers: effect of the monoamine oxidase-A gene promoter (MAOA-uVNTR). Biol Psychol (2008) 0.97
A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment. Transl Psychiatry (2011) 0.97
Constitutional mechanisms of vulnerability and resilience to nicotine dependence. Mol Psychiatry (2009) 0.96
Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J Autism Dev Disord (2008) 0.94
Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysis. Behav Brain Funct (2007) 0.93
Monoamine oxidase A regulates antisocial personality in whites with no history of physical abuse. Compr Psychiatry (2010) 0.92
Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo. J Neurosci (2008) 0.92
Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry (2007) 0.92
Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci (2007) 0.90
MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Mol Psychiatry (2013) 0.90
Anxiety in mice and men: a comparison. J Neural Transm (Vienna) (2009) 0.90
Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol (2011) 0.90
MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res (2011) 0.89
Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine. J Headache Pain (2010) 0.89
The role of the serotonergic system at the interface of aggression and suicide. Neuroscience (2013) 0.89
Deviant peer affiliation and antisocial behavior: interaction with Monoamine Oxidase A (MAOA) genotype. J Abnorm Child Psychol (2011) 0.86
Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment. Addict Sci Clin Pract (2010) 0.85
Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans. J Neural Transm (Vienna) (2009) 0.85
Genetic and environmental factors in complex neurodevelopmental disorders. Curr Genomics (2007) 0.84
Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Eur Arch Psychiatry Clin Neurosci (2009) 0.84
5-HTTLPR X stress in adolescent depression: moderation by MAOA and gender. J Abnorm Child Psychol (2013) 0.84
Genetic susceptibility for individual cooperation preferences: the role of monoamine oxidase A gene (MAOA) in the voluntary provision of public goods. PLoS One (2011) 0.83
Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder. BMC Med Genet (2011) 0.83
The association of DNA sequence variation at the MAOA genetic locus with quantitative behavioural traits in normal males. Hum Genet (2006) 0.83
Pharmacogenetics of anxiolytic drugs. J Neural Transm (Vienna) (2009) 0.83
Description and validation of a dynamical systems model of presynaptic serotonin function: genetic variation, brain activation and impulsivity. Behav Genet (2010) 0.82
Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder. Psychopharmacology (Berl) (2004) 0.82
A latent modeling approach to genotype-phenotype relationships: maternal problem behavior clusters, prenatal smoking, and MAOA genotype. Arch Womens Ment Health (2012) 0.82
Serotonin gene variants are unlikely to play a significant role in the pathogenesis of the sudden infant death syndrome. Respir Physiol Neurobiol (2013) 0.82
Attention Deficit Hyperactivity Disorder comorbid oppositional defiant disorder and its predominately inattentive type: evidence for an association with COMT but not MAOA in a Chinese sample. Behav Brain Funct (2009) 0.82
Lipid levels are associated with a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR). Med Sci Monit (2008) 0.81
ADHD and Disruptive Behavior scores - associations with MAO-A and 5-HTT genes and with platelet MAO-B activity in adolescents. BMC Psychiatry (2008) 0.80
Genotypes do not confer risk for delinquency but rather alter susceptibility to positive and negative environmental factors: gene-environmentinteractions of BDNF Val66Met, 5-HTTLPR, and MAOA-uVNTR [corrected]. Int J Neuropsychopharmacol (2014) 0.80
Gender difference in interactions between MAOA promoter uVNTR polymorphism and negative familial stressors on body mass index among Chinese adolescents. Pediatr Obes (2013) 0.80
Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways. Mol Psychiatry (2015) 0.80
The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders. Front Pharmacol (2013) 0.80
MAOA expression predicts vulnerability for alcohol use. Mol Psychiatry (2015) 0.80
Association of low-activity MAOA allelic variants with violent crime in incarcerated offenders. J Psychiatr Res (2014) 0.79
The genetic basis of panic disorder. J Korean Med Sci (2011) 0.79
Association analysis of monoamine oxidase A gene and bipolar affective disorder in Han Chinese. Behav Brain Funct (2008) 0.79
Association analysis of Rgs7 variants with panic disorder. J Neural Transm (Vienna) (2008) 0.79
Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response. J Neural Transm (Vienna) (2014) 0.79
Cognitive effects of genetic variation in monoamine neurotransmitter systems: a population-based study of COMT, MAOA, and 5HTTLPR. Am J Med Genet B Neuropsychiatr Genet (2010) 0.79
ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex. Neuropsychopharmacology (2011) 0.79
The challenges of psychopharmacogenetics. Am J Hum Genet (1999) 0.79
MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy. Transl Psychiatry (2016) 0.79
Predictive index for the onset of medication overuse headache in migraine patients. Neurol Sci (2013) 0.78
Genetic modulation of the serotonergic pathway: influence on weight reduction and weight maintenance. Genes Nutr (2013) 0.78
Negative predictors of clinical response to triptans in patients with migraine. Neurol Sci (2011) 0.78
Genetic influences on the neural and physiological bases of acute threat: A research domain criteria (RDoC) perspective. Am J Med Genet B Neuropsychiatr Genet (2015) 0.78
Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression. J Neural Transm (Vienna) (2015) 0.77
Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome. J Neurodev Disord (2014) 0.77
Underlying Mechanisms of Gene-Environment Interactions in Externalizing Behavior: A Systematic Review and Search for Theoretical Mechanisms. Clin Child Fam Psychol Rev (2015) 0.77
Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans. Pharmacogenomics J (2012) 0.77
Association of a functional variant of neuronal nitric oxide synthase gene with self-reported impulsiveness, venturesomeness and empathy in male offenders. J Neural Transm (Vienna) (2009) 0.77
The interactive effect of MAOA-LPR genotype and childhood physical neglect on aggressive behaviors in Italian male prisoners. Genes Brain Behav (2014) 0.77
Two functional serotonin polymorphisms moderate the effect of food reinforcement on BMI. Behav Neurosci (2013) 0.77
GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder. Mol Psychiatry (2017) 0.76
The role of monoamine oxidase A in aggression: Current translational developments and future challenges. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.76
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches. Oxid Med Cell Longev (2016) 0.76
Association of the calcyon neuron-specific vesicular protein gene (CALY) with adolescent smoking initiation in China and California. Am J Epidemiol (2011) 0.76
Sudden infant death syndrome (SIDS) and polymorphisms in Monoamine oxidase A gene (MAOA): a revisit. Int J Legal Med (2013) 0.76
Platelet monoamine oxidase B (MAO-B) activity and its relationship to DL-fenfluramine-induced prolactin response in healthy men. J Neural Transm (Vienna) (2005) 0.76
Prolactin levels in olanzapine treatment correlate with positive symptoms of schizophrenia: results from an open-label, flexible-dose study. Prim Care Companion J Clin Psychiatry (2009) 0.75
An analysis of the influence of selected genetic and hormonal factors on the occurrence of depressive symptoms in late-reproductive-age women. Int J Environ Res Public Health (2015) 0.75
Evidence of MAOA genotype involvement in spatial ability in males. Behav Brain Res (2014) 0.75
Evaluation of the relationship between 5-HTT and MAO gene polymorphisms, mood and level of anxiety among postmenopausal women. Int J Environ Res Public Health (2014) 0.75
Are there anxious genes? Dialogues Clin Neurosci (2002) 0.75
Amphetamine manipulates monoamine oxidase-A level and behavior using theranostic aptamers of transcription factors AP-1/NF-kB. J Biomed Sci (2016) 0.75
Monoamine oxidase A genotype, childhood trauma, and subclinical atherosclerosis: a twin study. Psychosom Med (2013) 0.75
Are dopamine-related genotypes risk factors for excessive gestational weight gain? Int J Womens Health (2013) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry (2007) 6.72
A potassium channel mutation in neonatal human epilepsy. Science (1998) 4.17
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (1995) 3.15
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry (1998) 3.07
A similarity-based method for genome-wide prediction of disease-relevant human genes. Bioinformatics (2002) 3.04
Mind reading: neural mechanisms of theory of mind and self-perspective. Neuroimage (2001) 3.03
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol (1998) 2.94
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry (1999) 2.90
Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry (2002) 2.85
Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Mol Psychiatry (2002) 2.65
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care (1997) 2.63
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Heterodimerization between light-regulated and ubiquitously expressed Arabidopsis GBF bZIP proteins. EMBO J (1992) 2.40
Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care (1997) 2.32
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Mol Psychiatry (2001) 2.27
Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A (1998) 2.22
Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A (2001) 2.19
TGA1 and G-box binding factors: two distinct classes of Arabidopsis leucine zipper proteins compete for the G-box-like element TGACGTGG. Plant Cell (1992) 2.18
The Hamilton scales and the Hopkins Symptom Checklist (SCL-90). A cross-national validity study in patients with panic disorders. Br J Psychiatry (1992) 2.16
Net costs of dementia by disease stage. Acta Psychiatr Scand (2011) 2.11
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm (1988) 2.10
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
[Systematic treatment of depression]. Versicherungsmedizin (1999) 2.05
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
CNTF and endogenous psychoses? Nat Genet (1996) 2.02
Exclusion of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13-22 locus. Mol Psychiatry (2002) 2.01
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry (2010) 2.00
Reconstitution of transcription factor SL1: exclusive binding of TBP by SL1 or TFIID subunits. Science (1994) 1.98
Clinical implications of endoscopic ultrasound: the American Endosonography Club Study. Gastrointest Endosc (1996) 1.98
HAT3.1, a novel Arabidopsis homeodomain protein containing a conserved cysteine-rich region. Plant J (1993) 1.97
Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res (1998) 1.95
DNA binding site preferences and transcriptional activation properties of the Arabidopsis transcription factor GBF1. EMBO J (1992) 1.94
Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry (2008) 1.92
The utility of the non-human primate; model for studying gene by environment interactions in behavioral research. Genes Brain Behav (2003) 1.91
Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. Am J Hum Genet (1998) 1.87
Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry (2001) 1.84
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
DNA microarray analysis identifies candidate regions and genes in unexplained mental retardation. Neurology (2007) 1.81
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78
Risk factors for incident mild cognitive impairment--results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). Acta Psychiatr Scand (2009) 1.76
Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm (1986) 1.75
Modulation of the IgH enhancer's cell type specificity through a genetic switch. Genes Dev (1991) 1.74
The symptom check-list, SCL-90-R: its use and characteristics in chronic pain patients. Eur J Pain (2000) 1.73
Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet (1996) 1.70
Assembly of transcriptionally active RNA polymerase I initiation factor SL1 from recombinant subunits. Science (1994) 1.70
Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun (1998) 1.69
The multiple carrier model of nonribosomal peptide biosynthesis at modular multienzymatic templates. J Biol Chem (1996) 1.67
Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry (1997) 1.66
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65
Evidence for linkage of spelling disability to chromosome 15. Am J Hum Genet (1998) 1.65
Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease. Br J Dermatol (2010) 1.63
Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut (2001) 1.63
A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol (2000) 1.61
Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry (2004) 1.60
Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry (1999) 1.59
Novel Hairless mutations in two kindreds with autosomal recessive papular atrichia. J Invest Dermatol (1999) 1.58
Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry (2010) 1.57
Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care. Br J Psychiatry Suppl (1998) 1.57
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med (2012) 1.56
Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome. J Pathol (2008) 1.56
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. Arch Gen Psychiatry (2001) 1.56
Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet (1996) 1.55
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B. Nat Genet (2000) 1.55
Exploring the genetic link between RLS and ADHD. J Psychiatr Res (2009) 1.55
A congenital teratoma with a cleft palate: report of a case. Br J Oral Maxillofac Surg (2005) 1.50
Limbic structures and lateral ventricle in schizophrenia. A quantitative postmortem study. Arch Gen Psychiatry (1990) 1.49
Essential functions of the human self model are implemented in the prefrontal cortex. Conscious Cogn (1999) 1.48
Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci (2000) 1.46
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med (2011) 1.45
An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet (1997) 1.45
A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry (2000) 1.45
A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet (2004) 1.45
Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry (2011) 1.44
Risk factors for new depressive episodes in primary health care: an international prospective 12-month follow-up study. Psychol Med (2002) 1.44